Fisher & Paykel Healthcare expects earnings to climb this year, as it releases new products into European and US markets, but says the volatile New Zealand dollar could act as a headwind.
The listed medical equipment company, which makes care products and machines to help breathing, made $71.6 million in the year to the end of March - up 15% on the previous year.
It expects to make between $70 and $75 million in the 2011 financial year.
Chief executive Michael Daniell says revenue growth in the second half of the year was boosted by the release of a new ICON flow generator range.
Spending on research and development will grow again this year, as the company develops its manufacturing capacity in Mexico.
Mr Daniell says he expects the company to be eligible for $2.4 million in Government support per year, under changes to research and development funding announced in the 2010 Budget.
Shares in Fisher & Paykel Healthcare fell 15 cents on Wednesday, to $3.25.
